AcquisitionOther

Tourmaline Bio, Inc. acquired Tourmaline Bio, Inc.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Tourmaline Bio, Inc. -> Tourmaline Bio, Inc. · $0.0001

As previously reported, pursuant to the terms of the ATM Sales Agreement, the Company could offer and sell up to $100.0 million of shares of its common stock, par value $0.0001 per share, from time to time through an “at the market” equity offering program und

Open source record (SEC) ↗